Revisión
Nuevos anticoagulantes orales en el tratamiento del tromboembolismo venoso: análisis crítico de los resultados clínicos
New oral anticoagulants in the treatment of venous thromboembolism: Critical analysis of clinical trials
J.A. Páramo
, A. Alfonso, R. Lecumberri
Autor para correspondencia
Servicio de Hematología, Clínica Universidad de Navarra, Pamplona, Navarra, España
Leído
7297
Vecesse ha leído el artículo
1240
Total PDF
6057
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 27 | 6 | 33 |
| 2025 11 | 82 | 16 | 98 |
| 2025 10 | 87 | 16 | 103 |
| 2025 9 | 84 | 19 | 103 |
| 2025 8 | 88 | 15 | 103 |
| 2025 7 | 102 | 12 | 114 |
| 2025 6 | 90 | 10 | 100 |
| 2025 5 | 136 | 10 | 146 |
| 2025 4 | 161 | 4 | 165 |
| 2025 3 | 153 | 12 | 165 |
| 2025 2 | 147 | 12 | 159 |
| 2025 1 | 179 | 5 | 184 |
| 2024 12 | 139 | 9 | 148 |
| 2024 11 | 147 | 16 | 163 |
| 2024 10 | 91 | 10 | 101 |
| 2024 9 | 202 | 9 | 211 |
| 2024 8 | 95 | 8 | 103 |
| 2024 7 | 116 | 5 | 121 |
| 2024 6 | 103 | 6 | 109 |
| 2024 5 | 156 | 11 | 167 |
| 2024 4 | 126 | 14 | 140 |
| 2024 3 | 128 | 11 | 139 |
| 2024 2 | 105 | 26 | 131 |
| 2024 1 | 103 | 9 | 112 |
| 2023 12 | 84 | 14 | 98 |
| 2023 11 | 94 | 20 | 114 |
| 2023 10 | 108 | 20 | 128 |
| 2023 9 | 78 | 12 | 90 |
| 2023 8 | 76 | 7 | 83 |
| 2023 7 | 74 | 13 | 87 |
| 2023 6 | 101 | 7 | 108 |
| 2023 5 | 109 | 18 | 127 |
| 2023 4 | 116 | 13 | 129 |
| 2023 3 | 101 | 19 | 120 |
| 2023 2 | 66 | 11 | 77 |
| 2022 1 | 57 | 11 | 68 |
| 2022 12 | 47 | 5 | 52 |
| 2022 11 | 74 | 18 | 92 |
| 2022 10 | 42 | 12 | 54 |
| 2022 9 | 60 | 46 | 106 |
| 2022 8 | 96 | 28 | 124 |
| 2022 7 | 100 | 24 | 124 |
| 2022 6 | 34 | 22 | 56 |
| 2022 5 | 56 | 12 | 68 |
| 2022 4 | 45 | 11 | 56 |
| 2022 3 | 72 | 21 | 93 |
| 2022 2 | 48 | 21 | 69 |
| 2021 1 | 50 | 23 | 73 |
| 2021 12 | 45 | 31 | 76 |
| 2021 11 | 69 | 20 | 89 |
| 2021 10 | 50 | 21 | 71 |
| 2021 9 | 36 | 28 | 64 |
| 2021 8 | 44 | 12 | 56 |
| 2021 7 | 26 | 14 | 40 |
| 2021 6 | 40 | 12 | 52 |
| 2021 5 | 57 | 17 | 74 |
| 2021 4 | 66 | 23 | 89 |
| 2021 3 | 33 | 8 | 41 |
| 2021 2 | 21 | 12 | 33 |
| 2020 1 | 28 | 9 | 37 |
| 2020 12 | 16 | 15 | 31 |
| 2020 11 | 19 | 4 | 23 |
| 2020 10 | 14 | 10 | 24 |
| 2020 9 | 17 | 6 | 23 |
| 2020 8 | 11 | 8 | 19 |
| 2020 7 | 11 | 13 | 24 |
| 2020 6 | 13 | 12 | 25 |
| 2020 5 | 17 | 9 | 26 |
| 2020 4 | 9 | 11 | 20 |
| 2020 3 | 3 | 6 | 9 |
| 2020 2 | 0 | 2 | 2 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 0 | 10 | 10 |
| 2019 11 | 0 | 3 | 3 |
| 2019 9 | 0 | 1 | 1 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 0 | 1 | 1 |
| 2019 5 | 0 | 13 | 13 |
| 2019 4 | 0 | 4 | 4 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 0 | 3 | 3 |
| 2018 7 | 1 | 0 | 1 |
| 2018 2 | 9 | 1 | 10 |
| 2018 1 | 18 | 7 | 25 |
| 2017 12 | 5 | 1 | 6 |
| 2017 11 | 24 | 2 | 26 |
| 2017 10 | 31 | 4 | 35 |
| 2017 9 | 18 | 2 | 20 |
| 2017 8 | 33 | 2 | 35 |
| 2017 7 | 31 | 1 | 32 |
| 2017 6 | 29 | 4 | 33 |
| 2017 5 | 32 | 4 | 36 |
| 2017 4 | 29 | 3 | 32 |
| 2017 3 | 49 | 37 | 86 |
| 2017 2 | 41 | 5 | 46 |
| 2016 1 | 26 | 4 | 30 |
| 2016 12 | 42 | 14 | 56 |
| 2016 11 | 55 | 12 | 67 |
| 2016 10 | 57 | 17 | 74 |
| 2016 9 | 45 | 7 | 52 |
| 2016 8 | 46 | 9 | 55 |
| 2016 7 | 28 | 3 | 31 |
| 2016 6 | 30 | 18 | 48 |
| 2016 5 | 27 | 20 | 47 |
| 2016 4 | 26 | 14 | 40 |
| 2016 3 | 37 | 19 | 56 |
| 2016 2 | 1 | 0 | 1 |
| 2015 1 | 0 | 2 | 2 |
| 2015 11 | 0 | 1 | 1 |
| 2015 10 | 3 | 1 | 4 |
| 2015 9 | 1 | 1 | 2 |
| 2015 8 | 3 | 1 | 4 |
Mostrar todo
